Feng XL - Search Results

1

Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study.

Shi GM, Huang XY, Wen TF, Song TQ, Kuang M, Mou HB, Bao LQ, Zhao HT, Zhao H, Feng XL, Zhang BX, Peng T, Zhang YB, Li XC, Yu HS, Cao Y, Liu LX, Zhang T, Wang WL, Ran JH, Liu YB, Gong W, Chen MX, Cao L, Luo Y, Wang Y, Zhou H, Yang GH, Fan J, Zhou J. Shi GM, et al. Among authors: feng xl. Cancer Med. 2023 Feb;12(4):4137-4146. doi: 10.1002/cam4.5273. Epub 2022 Sep 20. Cancer Med. 2023. PMID: 36127767 Free PMC article. Clinical Trial.

2

Terlipressin in the treatment of hepatorenal syndrome: A systematic review and meta-analysis.

Wang H, Liu A, Bo W, Feng X, Hu Y. Wang H, et al. Medicine (Baltimore). 2018 Apr;97(16):e0431. doi: 10.1097/MD.0000000000010431. Medicine (Baltimore). 2018. PMID: 29668606 Free PMC article. Review.

3

Long non-coding RNA CASC2 upregulates PTEN to suppress pancreatic carcinoma cell metastasis by downregulating miR-21.

Zhang H, Feng X, Zhang M, Liu A, Tian L, Bo W, Wang H, Hu Y. Zhang H, et al. Cancer Cell Int. 2019 Jan 16;19:18. doi: 10.1186/s12935-019-0728-y. eCollection 2019. Cancer Cell Int. 2019. PMID: 30675129 Free PMC article.

4

Strategies and Recent Advances on Improving Efficient Antitumor of Lenvatinib Based on Nanoparticle Delivery System.

Wang H, Bo W, Feng X, Zhang J, Li G, Chen Y. Wang H, et al. Int J Nanomedicine. 2024 Jun 10;19:5581-5603. doi: 10.2147/IJN.S460844. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38882543 Free PMC article. Review.

5

Neoadjuvant-Based Triple Therapy for Hepatocellular Carcinoma with Type I/II Portal Vein Tumor Thrombosis.

Hou G, Zhang F, Feng X, Chen Y, Zhang J, Wang H. Hou G, et al. J Hepatocell Carcinoma. 2024 Aug 20;11:1581-1595. doi: 10.2147/JHC.S479810. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 39184154 Free PMC article.

6

Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma patients after curative resection, a systematic review and meta-analysis.

Wang H, Liu A, Bo W, Feng X, Hu Y, Tian L, Zhang H, Tang X. Wang H, et al. Dig Liver Dis. 2016 Nov;48(11):1275-1282. doi: 10.1016/j.dld.2016.07.010. Epub 2016 Jul 18. Dig Liver Dis. 2016. PMID: 27481586 Review.

7

Fibrosis-4 Model Influences Results of Patients with Hepatocellular Carcinoma Undergoing Hepatectomy.

Wang H, Liu A, Bo W, Feng X, Hu Y, Tian L, Zhang H, Tang X, Zhang L. Wang H, et al. Biomed Res Int. 2018 Jul 2;2018:4305408. doi: 10.1155/2018/4305408. eCollection 2018. Biomed Res Int. 2018. PMID: 30057907 Free PMC article.

8

Tumor burden score is superior to primary liver cancer stages in predicting prognosis for patients with combined hepatocellular-cholangiocarcinoma after surgery: A multi-center study.

Jiang C, Qin F, Yan J, Zou J, Wang H, Zhang H, Feng X, Hou G. Jiang C, et al. Eur J Surg Oncol. 2024 Nov;50(11):108610. doi: 10.1016/j.ejso.2024.108610. Epub 2024 Aug 22. Eur J Surg Oncol. 2024. PMID: 39213695 Free article.

9

Overexpression of rhophilin 2 promotes pancreatic ductal adenocarcinoma.

Bo W, Feng X, Tang X. Bo W, et al. Oncol Lett. 2021 Jan;21(1):76. doi: 10.3892/ol.2020.12337. Epub 2020 Nov 25. Oncol Lett. 2021. PMID: 33365087 Free PMC article.

10

Immediate postoperative Fibrosis-4 predicts postoperative liver failure for patients with hepatocellular carcinoma undergoing curative surgery.

Wang H, Li L, Bo W, Liu A, Feng X, Hu Y, Tian L, Zhang H, Tang X, Zhang L, Zhang M. Wang H, et al. Dig Liver Dis. 2018 Jan;50(1):61-67. doi: 10.1016/j.dld.2017.09.127. Epub 2017 Oct 4. Dig Liver Dis. 2018. PMID: 29054394

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

445 results

Search Page

Filters